Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice

This journal activity provides a summary of the current state of Early-Stage Breast Cancer radiotherapy treatments and an overview of the clinical data that can be used to create a more personalized radiotherapeutic management of patients based on molecular profiling and risk stratification. Data on partial breast irradiation, moderate and ultra-hypofractionation, boost radiotherapy for high-risk disease, radiotherapy omission, primary radiotherapy, and re-irradiation are presented. Limitations and areas of controversy in said data are also highlighted.

Please visit Early-Stage Breast Cancer: A Critical Review of Current and Emerging Practice to read the related journal article online. 

This activity is available from November 14, 2024, through 11:59 p.m. Eastern time on November 13, 2026.

Target Audience

This course is designed to meet the interest of radiation oncologists and radiation oncology residents.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Summarize current clinical data for Early Stage Breast Cancer comparing whole breast irradiation to partial breast irradiation, different fractionation schemes including ultra hypofractionation, omission of radiotherapy and reirradiation in terms of ipsilateral breast tumor recurrence rates and toxicity.
  • Identify opportunities for more personalized treatments of ESBC patients based on molecular profiling and risk stratification, and limitations in the current available data.
  • Discuss areas of ongoing investigation in the personalization of ESBC treatment that will influence treatment approaches in the coming years.

 

 

 

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.
Course opens: 
11/14/2024
Course expires: 
11/13/2026
Cost:
$49.00
Rating: 
0

Sue Yom, MD, PhD, FASTRO is employed by the University of California and receives compensation from Bristol-Myers Squibb, NRG Oncology, EMD Serono.

The person(s) above served as the developer(s) of this activity. Additionally, the ASTRO Education Committee had control over the content of this activity.

All relevant relationships have been mitigated.

Disclosure link: 
ASTRO Education Committee

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Certificate of Attendance
    This activity was designated for 1.00 AMA PRA Category 1 Credit™.

Price

Cost:
$49.00
Please login or register to take this course.

Course Fees:
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

  • Nonmember: $49
  • Member: $0

Policies:
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.

Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.

The activity and its materials will only be available on the ASTRO website until November 13, 2026, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.